Serpentine Ventures — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Luna HealthAug 2025
Overnight automated insulin delivery
Wilmington, US
John Sjolund(Chief Executive Officer of the Issuer)Jon Brilliant(Chief Financial Officer of the Issuer)
BoardPeter N. Townsend(Director)Justin Klein(Director)inAmrinder Singh(Director)in
Co-investorsVensana Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.